Nafcillin sodium

This classification denotes an anti-bacterial agent with the molecular formula C21H21N2O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49G3001BCK, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo- but more generally known as nafcillin sodium, which bears US NIH Compound Identifier 8982. European Medicines Agency schedules Nafcillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03375MIG. Most nations, for tariff and trade purposes, schedule nafcillin sodium under HS 29411090 and SITC 54131. As of Q4 2014, NAFCILLIN SODIUM remains US FDA's Preferred Term for this commodity. Nafcillin sodium bears US NLM identifiers UMLS ID C0037531 and NCI Concept Code C29281. SMILES: CCOC1CCC2CCCCC2C1C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].